GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytoDyn Inc (STU:296) » Definitions » FCF Yield %

CytoDyn (STU:296) FCF Yield % : -1.89 (As of Apr. 22, 2025)


View and export this data going back to 2016. Start your Free Trial

What is CytoDyn FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CytoDyn's Trailing 12-Month Free Cash Flow is €-4.73 Mil, and Market Cap is €220.63 Mil. Therefore, CytoDyn's FCF Yield % for today is -1.89%.

The historical rank and industry rank for CytoDyn's FCF Yield % or its related term are showing as below:

STU:296' s FCF Yield % Range Over the Past 10 Years
Min: -1.89   Med: 0   Max: 0
Current: -1.89


STU:296's FCF Yield % is ranked better than
78.57% of 1498 companies
in the Biotechnology industry
Industry Median: -15.235 vs STU:296: -1.89

CytoDyn's FCF Margin % for the quarter that ended in Feb. 2025 was 0.00%.


CytoDyn FCF Yield % Historical Data

The historical data trend for CytoDyn's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoDyn FCF Yield % Chart

CytoDyn Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.64 -9.33 -32.96 -10.48 -4.75

CytoDyn Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.17 -2.85 12.16 -9.95 -5.89

Competitive Comparison of CytoDyn's FCF Yield %

For the Biotechnology subindustry, CytoDyn's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoDyn's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CytoDyn's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CytoDyn's FCF Yield % falls into.


;
;

CytoDyn FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CytoDyn's FCF Yield % for the fiscal year that ended in May. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.158 / 213.828918
=-4.75%

CytoDyn's annualized FCF Yield % for the quarter that ended in Feb. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.758 * 4 / 322.86391
=-5.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CytoDyn FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


CytoDyn FCF Yield % Related Terms

Thank you for viewing the detailed overview of CytoDyn's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CytoDyn Business Description

Traded in Other Exchanges
Address
1111 Main Street, Suite 660, Vancouver, WA, USA, 98660
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.

CytoDyn Headlines

No Headlines